Blog | Nov. 17, 2014

American College of Rheumatology Annual Meeting 2014 – Day 2

Today’s sessions will focus on pediatric lupus and biomarkers, including a Foundation-funded research program about pediatric lupus in South Africa. Learn more!

General News | Nov. 15, 2014

Lupus Research Studies Widen Understanding

Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.

Research News | Oct. 29, 2014

Study Identifies Possible Method to Block Production of Antibodies Associated with Lupus

Lupus Foundation of America supported study demonstrates that blocking STAT5 reduces the production of CD154 by half.

Research News | Oct. 20, 2014

Intensive Follow-Up Recommended for People Diagnosed with Lupus During Childhood

Adolescent-onset lupus has worse prognosis and increased risk of lupus-related kidney disease and death.

General News | Sep. 30, 2014

Foundation Announces Pediatric Lupus Research Grantee & LIFELINE Grant Program™ Recipients

The Lupus Foundation of America announced four grants that will allow lupus investigators to continue critical lupus research. Another grant will be used to develop a groundbreaking diagnostic tool for children with lupus-related kidney inflammation, or lupus nephritis.

General News | Sep. 24, 2014

Foundation Welcomes NIH’s Accelerating Medicines Partnership in Lupus and RA Grantees

The Lupus Foundation of America congratulates and welcomes the first 11 new research groups that have been awarded grants as part of the Accelerating Medicines Partnership in Lupus and Rheumatoid Arthritis (AMP Lupus and RA) Network.

General News | Sep. 09, 2014

Leading Orgs Take to the Hill to Discuss Need to Accelerate New Medicines for Lupus & Other Diseases

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing

Research News | Aug. 01, 2014

Clinical Trial of Adult Stem Cells Takes Another Step Forward

Study funded by the Foundation's National Lupus Research Program secures NIH planning grant to develop a multi-center trial of mesenchymal stem cells.